London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Totally agree Frankmu. Dream products is the phrase.
We have two products with multi billion dollar potential, and a share price of 15p! Madness.
The key reason for buying a share is potential, and these products have bags of that.
The Brokers need to pull their heads out of the horses @rse and wake up.
In 12 months the share price could be anywhere between £1 and £5. Take your pick.
If we also start to see some developments in the pain relief gel then who knows where this could go.
Will start attract much more attention now for sure. Happy days.
Word of the day: 'fructify'
A keeper!!
The CBD gel & the Erection dysfunction remedy cream, 2 dream products for a better quality of life if they fructify
Baldy pop’s
Very nice
who was saying this is a one trick pony the other day. i said at the time he had forgotten this
2.8 billion us dollars. you only need to google it!
Does anybody know the annual value of the CBD Market for pain relief?
Must be quite sizeable?
Would appreciate it if anyone has any links to information.
morning be..glad you liked the suggestion .i hope to hear further. glad also to see today's RNS, simply from the point of view that it fulfils (albeit a few days late) the indication in the interview that we would be updated on this in july. not going to comment on the substance as its very early days to attach any to it , but pleased that information time lines have been adhered to.
RNS: GREAT NEWS.
Another significant string to the bow of FUM with CBD.
So much to look forward to.
theItalian, an excellent idea...one I was already considering. There is nothing like talk of legal action to make a BOD squirm...and miraculously change the wording of their blurb.
The 'problem' for shareholders is to work out what is spin & what is the truth....something IMO that is becoming exceedingly difficult with FUM (since Ken effectively took over the helm).
PS it may not be Ken but he does seem to be in charge now...in all but name.
be you are very worked up about this aren't you. perhaps i can politely suggest that you email barder or james apprising then of your very strong opinion that their chosen form of wording is laying them open to law suits by disappointed investors and to serious repetitional damage in the eyes of the pharma industry as producers of duplicitous and misleading information.if you do I'm sure we will all be very interested to see their response. i fear this is the only way you will be able to resolve this issue to your satisfaction.of course you may not get a reply but no harm in trying if you feel so strongly about it.
"Med3000 is a version of Dermasys that was reformulated specifically for the ED application!..."
===========================================
Dosanddonts, is almost correct. Yes, FUM reformulate the base Dermasys for each application, the aim is to maximise the transfer of the active ingredient through the skin barrier. That is correct. But it is the active ingredient that was 'specifically designed' for ED treatment and NOT the base dermasys (since renamed MED3000). It was very clever of someone at FUM (probably Ken) to suggest that it was MED3000 (base dermasys) that was 'specifically designed for ED'....very clever, very sneaky AND 100% unadulterated b0ll0cks!!!
The thing is, the base dermasys was 'designed' to be inert - hence all that GRAS references on their website. Base dermasys was renamed MED3000 and it was designed to be an inert carrier of the active compound. Hence why MED3000 was used as the 'placebo' in the P3 trial. It would have been a bit daft to have a randomized placebo-controlled trial when the placebo being used was actually 'specifically designed' to treat ED. As I say complete 100% b0ll0cks!!
FUM are leaving themselves open to an investor lawsuit for publishing misleading information IMO. And also creating an image - to potential pharma partners - as a company that isn't always truthful. The funny thing is that they don't need to try to fool us. Just stick to the truth FUM
Med3000 is a version of Dermasys that was reformulated specifically for the ED application! Therefore new patents are requested to protect the new formulation, as they are for all reformulated versions. I’m sure this is stated on the FUM website. Sure this has been mentioned on this forum before , As has the placebo nonsense! Same people going round in circles spouting the same old crap again & again! Good luck everyone but don’t listen to the people on here, they are full of it! & we know who they are! (Playing shareholders to feather their own nests)